McKesson moves to buy out remaining shares of Celesio

SAN FRANCISCO  — McKesson on Friday announced that the wholesaler has launched a voluntary public takeover offer for the remaining outstanding shares of Celesio through its indirect wholly-owned subsidiary Dragonfly. 

There are no closing conditions in relation to the takeover offer. McKesson currently exceeds 75% ownership of Celesio shares on a fully diluted basis.

The publication of the offer document for the takeover offer has been approved by the Bundesanstalt für Finanzdienstleistungsaufsicht and is now available on GlobalHealthcareLeader.com in German and in an English translation. 

Celesio shareholders can now accept the takeover offer and tender their shares in Celesio at the offer price of €23.50 per share ($32.45 per share). The initial acceptance period will end on April 2, 6 p.m. EST and will be followed by an additional two-week acceptance period following the publication of the results of takeover offer.